eculizumab-aagh

eculizumab-aagh (EPYSQLI) is an FDA-listed pharmaceutical active ingredient. Route of administration: solution. Current US regulatory status: approved.

EPYSQLI is a marketed brand name for eculizumab-aagh. Check FDA Drugs@FDA for the current US label holder and prescribing information.

eculizumab-aagh has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.